Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatBelgian patent proposal -- good sentiments, poor drafting?
By Jeremy
The IPKat's linguistic limitations have been sorely exposed by his friend Kristof Kneefs, who has sent him this link to a proposal from some deputies in the Belgian Parliament to insert a new exception into the Belgian Patent Act in order to permit the export of generic pharmaceuticals to developing countries.Right: the IPKat prays for the compulsory licensing of Belgian chocolates ...
Kristof explains in brief that the amendment would read as follows:
"Article 28: The rights confered by a patent do not extend to ... (g) the export of generic versions of patented medicinal products to developing countries that have issued compulsory licences, to developing countries where those medicinal products have not been patented, or to developing countries that make use of the flexibility provided for in Article 30 of the TRIPs agreement".Adds Kristof:
"I think it is highly unlikely that the proposal would pass the vote of parliament, as the authors are members of a minority party.The IPKat wonders whether Belgium has the equivalent of the committee stage in the UK, at which wrinkled drafting can be ironed out. Merpel wonders what measures would be proposed so as to ensure that any products made for those laudable purposes would end up there and not return to the European Union for sale on a highly profitable basis.Second, if the exception only extends to exports, wouldn't the generics still be infringing the patent by producing the medicines, even if they were destined for export? (the proposal contains no further amendments)
Third, "to developing countries that have issued compulsory licences": that's rather broad, is it not? This would imply that the export of patented pharmaceutical A to country B would be permitted if country B has issued a compulsory licence for pharmaceutical C.
Conclusion: a lot of good intentions, but poor drafting".
TRIPs and pharmaceutical patents: the World Trade Organization fact sheet here
Full post as published by IPKat on April 06, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Clearwire Service
alleging poor quality and unfairly charging early termination fees.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

Belgian Court Orders Google To Stop Publishing News Content
Two male convicts marry in Belgian jail
Belgium pushes for cross-border pensions
Belgian author chooses aid in dying
Belgium government, banks to pay $170M to Holocaust survivors
A checklist for drafting good contracts









